Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Debt Growth
-3.97%
Quarterly · Period ending:
LCTX Debt Growth
Latest reported-3.97%period ending
Latest reported-3.97%period ending
LCTX Quarterly Debt Growth (QoQ) (0.00% → -3.97%)
Latest values, visible window
High-resolution chart · PNG
LCTX debt growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Debt Growth |
|---|---|
| -3.9683% | |
| -1.0335% | |
| -7.707% | |
| 21.6806% | |
| -4.0107% | |
| -10.7399% | |
| -8.5818% | |
| -6.8113% | |
| -9.3116% | |
| 10.2304% | |
| -4.1558% | |
| -9.5182% | |
| -6.4321% | |
| -6.6222% | |
| 39.1429% | |
| 33.3333% | |
| -17.8725% | |
| -8.7438% | |
| 3.1285% | |
| -6.3426% | |
| -18.3277% | |
| -7.1373% | |
| 34.6831% | |
| -37.9777% | |
| -5.2555% | |
| -6.4822% | |
| -2.7108% | |
| 8.9865% | |
| -4.2624% | |
| 124.7682% | |
| 451.0949% | |
| -70.1308% | |
| -3.9106% | |
| -6.5884% | |
| 6.4583% | |
| -64.6626% | |
| 9.8383% | |
| -6.8307% | |
| 24.8667% | |
| 20.3396% | |
| -57.0572% | |
| 20.9289% | |
| 7.3638% | |
| 30.9366% | |
| 350.5483% | |
| 52.8791% | |
| 399.2923% | |
| -8.2165% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| -95.9127% | |
| -5.8361% | |
| 86.6381% | |
| -31.2626% | |
| 42.5736% | |
| 47.1823% | |
| 82.4509% | |
| 102.451% | |
| 15.524% | |
| 206.37% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 9.4223% | |
| 9.0815% | |
| -2.5524% | |
| 6.4533% | |
| 6.1932% | |
| 5.9306% | |
| 5.6657% | |
| 5.3999% | |
| -48.3247% | |
| 570% |